Ask AI
Committee MeetingHouse

Examining FDA’s Generic Drug and Biosimilar User Fee Programs

Held

Thursday, March 2, 2017
Rayburn House Office Building 2123

Held by

House Energy and Commerce Subcommittee on Health

Watch / read on Congress.gov
Examining FDA’s Generic Drug and Biosimilar User Fee Programs — Informed